MPML yields 2000000.00% · MRK yields 2.81%● Live data
📍 MPML pulled ahead of the other in Year 1
Combined, MPML + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MPML + MRK for your $10,000?
MPM Technologies, Inc., through its subsidiaries, designs, engineers, supplies, and services air pollution control systems for environmental and industrial companies in the United States and internationally. The company provides air pollution control systems by utilizing wet and dry scrubbers, wet electrostatic precipitators, and venturi absorbers that control air pollution. It also involves in the development and commercialization of Skygas, a waste-to-energy process that converts solid and semi-solid wastes into a clean-burning medium BTU gas that can be used for steam production for electric power generation, as well as for downstream conversion into chemicals. The company's Skygas technology is used for the disposal and gasification of carbonaceous wastes, such as municipal solid waste, municipal sewage sludge, pulp and paper mill sludge, auto fluff, medical waste, and used tires. It has a strategic alliance with Foton Technologies, LLC to develop projects to produce power, chemicals, and liquid fuels utilizing Skygas gasification-derived syngas. The company was formerly known as Montana Precision Mining, Ltd. and changed its name to MPM Technologies, Inc. in August 1995. MPM Technologies, Inc. was founded in 1983 and is based in Spokane Valley, Washington. MPM Technologies, Inc. operates as a subsidiary of Carbon Cycle Investments, LLC.
Full MPML Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.